Balagangadhar R. Totapally

Balagangadhar R. Totapally

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Balagangadhar R. Totapally has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oxygenation Indices with Oxygen Challenge Test in Neonates During VA ECMO

    by Abhinav Totapally, Camila De Avila, Keith Meyer, Lian Santiago, Felipe Pedroso, Fuad Alkhoury, Balagangadhar R. Totapally

    Objective: To evaluate the response of various oxygenation indices to the oxygen challenge test (OCT), prior to decannulation, in neonates supported with VA ECMO for respiratory indications, and to compare these responses between survivors and non-survivors. Design: Single-center retrospective observational study. Setting: Single, tertiary care, 40-bed Pediatric Intensive Care Unit in Miami, Florida. Patients: Neonates cannulated to VA ECMO for respiratory failure from 2012 to 2022 who had an OCT. Patients with congenital heart disease were excluded. Measurements and Main Results: A total of 63 neonates were included, of whom 13 patients died (20.6%). Oxygenation indices compared before and during OCT include PaO2, Delta PaO2, P/F ratios, Alveolar-arterial gradient, arterial/alveolar ratios, and shunt fraction. The Wilcoxon signed-rank test demonstrated increases in all oxygenation indices during OCT compared to pre-OCT, except for P/F ratios. There were no differences in oxygenation indices between survivors and non-survivors during OCT. However, after decannulation, all oxygenation indices were worse in non-survivors (p < 0.05). Linear regression analysis demonstrated that delta FiO2 on the ventilator, P/F before OCT, and ECMO flow during OCT significantly affected PaO2 response during OCT. Shunt fraction above 28.8% after decannulation demonstrated the highest discriminatory ability for mortality (AUC 0.853). Conclusions: The OCT response during ECMO is not a reliable predictor of survival in neonates on VA ECMO, and its value in assessing readiness for ECMO trial-off warrants further evaluation. Further studies investigating the role of oxygenation indices at the time of trial-off for predicting outcomes may be helpful.

  • Open Access

    Addressing Contemporary Challenges in Pediatric Critical Care Medicine

    by Balagangadhar R. Totapally

    Pediatric critical care medicine has evolved into a highly specialized discipline that continues to adapt to the changing realities of clinical practice

  • Open Access

    Neonatal and Pediatric Transport: A Contemporary Review

    by Keith Meyer, Balagangadhar R. Totapally

    Safe transport of critically ill infants and children is an essential component of high-quality, pediatric regionalized care. The modern transport environment blends principles of critical care medicine, aviation physiology, provider training, and coordinated systems of care. This review provides an updated examination of current practices in neonatal and pediatric transport, including team structure, clinical bundles, operational considerations, and emerging technologies. Special attention is given to rapidly evolving areas, including data-informed dispatch, real-time clinical decision support, and next-generation devices. The review closes with a discussion of future priorities for research, workforce development, and system design.


  • The Prevalence and Trend of Nontuberculous Mycobacterial Infection in Hospitalized Children in the United States From 2000 to 2022

    by Meghana Totapally, Keith Meyer, Balagangadhar R. Totapally

    Background: Nontuberculous mycobacteria (NTM) are increasingly recognized as significant pathogens, particularly in immunocompromised children. However, population-based data on pediatric NTM hospitalizations in the United States are scarce. The objective of our study was to describe the national epidemiology and analyze trends of NTMs among hospitalized children. Methods: A retrospective serial cross-sectional study using the 2000–2022 Kids’ Inpatient Database was conducted. NTM infections were identified using International Classification of Diseases, Ninth and Tenth Revisions codes, and demographics, trends and clinical outcomes were compared with non-NTM discharges. Sample weighting was employed to produce national estimates. Results: Of a total of 26.1 million discharges from 2000 to 2022, 5508 had NTM infections (0.02%). NTM infections were more common in older White children with private insurance and higher household income and disproportionately occurred in urban locations, children’s hospitals and in the Western United States. The prevalence of NTM hospitalizations increased from 1.2 per 10,000 discharges in 2000 to 2.6 per 10,000 discharges in 2022 ( P < 0.001). Children with NTM infections had higher rates of complex chronic conditions, cystic fibrosis, HIV infection and invasive mechanical ventilation compared with other discharges. They also experienced significantly longer hospital stays, higher hospital charges and a higher mortality rate. Conclusions: The prevalence of NTM infections among hospitalized children in the United States has increased from 2000 to 2022. Pediatric NTM infections are associated with substantial clinical and economic burden, predominantly affecting patients who are immunocompromised or have chronic conditions. Enhanced awareness, surveillance and targeted research are needed to improve prevention and management strategies.


  • Open Access

    A Comprehensive Review of Pediatric Necrotizing Pneumonia

    by Manette Ness-Cochinwala, Balagangadhar R. Totapally

    Necrotizing pneumonia is a serious complication of pediatric pneumonia, characterized by liquefaction and cavitation of the lung parenchyma. Streptococcus pneumoniae and Staphylococcus aureus are the most implicated organisms. Mycoplasma pneumoniae has been an increasingly recognized pathogen, especially is Asian and Pseudomonas aeruginosa is mainly noted in a higher percentage of patients with complex chronic conditions. Clinical presentation typically includes fever, respiratory distress, and failure to respond to standard antibiotic therapy. These patients are more likely to have pleural involvement in the form of effusion or empyema and a higher need for respiratory support. Diagnosis is typically through a combination of chest radiographs, lung ultrasound, and chest computed tomography. Management is primarily via prolonged intravenous antibiotics that cover the above organisms, though pleural drainage with fibrinolytics is often required. Surgical intervention is often reserved for refractory cases that fail initial fibrinolytic therapy. Prognosis is usually favorable in the short and long term, though early recognition and appropriate management are imperative to reduce the duration of illness and morbidity.


  • Open Access

    Clinical Characteristics and Outcomes for Neonates with Respiratory Failure Referred for Extracorporeal Membrane Oxygenator (ECMO) Support

    by Pooja Musuku, Keith Meyer, Felipe E. Pedroso, Fuad Alkhoury, Balagangadhar R. Totapally

    Objective: The aim of this study was to describe the presenting characteristics and outcomes of neonates with respiratory failure referred for extracorporeal membrane oxygenation (ECMO) support, compare those who received ECMO support (ECMO group) to those who did not (non-ECMO group), and evaluate the predictive variables requiring ECMO support. Methods: All neonates (<15 days) with respiratory failure (without congenital diaphragmatic hernia or congenital heart disease) referred to our regional ECMO center from 2014 to 2023 were included in this retrospective study. Patient demographics, birth history, and clinical and outcome variables were analyzed. Oxygenation indices and vasoactive–inotropic scores obtained at PICU arrival and four hours after arrival were compared between the two groups using ROC analysis, with ECMO initiation as an outcome variable. Youden’s index was used for optimal threshold values. Chi-square, Mann–Whitney U, and binary logistic regression were used for comparative analyses. Results: Out of the 147 neonates, 96 (65%) required ECMO support. The two groups significantly differed in the prevalence of pulmonary hypertension (pHTN; systemic or suprasystemic pulmonary pressures), lactate level, and oxygenation indices. Mortality was not different between the two groups. Presence of oxygen saturation index (OSI) ≥ 10 had a sensitivity 96.8% in predicting the need for ECMO support. On regression analysis, OSI and pHTN were independent predictors of ECMO support. Conclusions: Oxygenation indices and echo findings predict the need for ECMO support in neonatal hypoxemic respiratory failure. These findings help non-ECMO centers make appropriate and timely transfers of neonates with respiratory failure to ECMO centers.


  • Demographic and Clinical Characteristics of Children with Primary Cardiac Tumors Hospitalized from 1997 to 2019 in the United States

    by Balagangadhar R. Totapally, Seevitha Totapalli, Anushree Malhotra-Hans, Keith Meyer

    Cardiac tumors in children, although rare, can lead to obstruction of valves or cardiac conduction problems. Large multi-site or national data on pediatric cardiac tumors is lacking. The objective of this study was to determine the prevalence of primary cardiac tumors in hospitalized children from 1997 to 2019 in the US and analyze the demographic and clinical characteristics of children with cardiac tumors. We conducted a cross-sectional analysis using the Healthcare Cost and Utilization Project's Kid's Inpatient Database from 1997 to 2019. Children with cardiac tumors were identified using ICD-9 and ICD-10 diagnosis codes. The prevalence is presented per 100,000 hospital discharges and 1,000,000 age-specific US population. The Chi-square test was used to compare the discharges with and without cardiac tumors for demographic and clinical variables. The Chi-square for linear trend (Extended Mantel–Haenszel) test was used for trend analyses. There were 3,166 discharges with primary cardiac tumors out of a total of 55.1 million discharges with a hospitalization rate of 5.8 per 100,000 discharges and 4.82 per million US children. Out of all children with cardiac tumors, 29.9% were neonates, 20.7% were infants, and 71% were children less than 5 years of age. Males comprised 52.9% of all cases. An increase in the prevalence of cardiac tumors from 1997 to 2019 was observed (p < 0.001). Of all admissions with cardiac tumors, 88.9% were reported benign, and 37.3% were admitted to Children's Hospitals. Cardiac arrhythmias were reported in 19.2%, seizures in 28%, and stroke in 1.4%. 51.9% of cases were associated with tuberous sclerosis. Cardiac surgical procedures were performed in 13.9% of patients. The overall hospital mortality rate was 1.6%. Primary cardiac tumor is a rare condition in children and is most common in neonates and young children. Most pediatric cardiac tumors are benign, and many are associated with tuberous sclerosis.

  • Open Access

    Thrombocytopenia in Critically Ill Children: A Review for Practicing Clinicians

    by Balagangadhar R. Totapally, Abhinav Totapally, Paul A. Martinez

    Thrombocytopenia frequently occurs in patients before, during, and after admission to Pediatric Intensive Care Units (PICUs). In critically ill children, it is often due to multifactorial causes and can be a sign of significant organ dysfunction. This review summarizes the potential causes/mechanisms of thrombocytopenia in acutely ill children, their identification, and treatments, with special attention paid to septic patients. The mechanisms of thrombocytopenia include decreased production and sequestration, but the most common reason is increased destruction or consumption. This review specifically reviews and compares the presentation, pathogenesis, and treatment of disseminated intravascular coagulation (DIC) and the thrombotic microangiopathic spectrum (TMA), including thrombocytopenia-associated multiorgan failure (TAMOF), hemolytic uremic syndrome, and other diagnoses. The other etiologies discussed include HLH/MAS, immune thrombocytopenia, and dilutional thrombocytopenia. Finally, this review analyzes platelet transfusions, the various thresholds, and complications.


  • Prevalence and outcomes of air leak syndrome and subtypes in neonates in the United States

    by Adam Beaton, Prithvi Sendi, Paul A Martinez, Balagangadhar R Totapally

    Objectives: To describe the prevalence, risk factors, and outcomes for neonatal air leak syndrome and its subtypes (pneumothorax, pneumomediastinum, pneumopericardium, pulmonary interstitial emphysema, and pneumoperitoneum), evaluate variables associated with the development of air leak, and analyze the national trend of neonatal air leak syndrome in the United States. Methods: A retrospective cross-sectional analysis of neonates was performed using the Kids’ Inpatient Database. Univariate and multivariable analyses were used to compare neonates with and without air leak syndrome and its subtypes using the 2016 and 2019 data. Data from 1997 to 2019 were used for trend analysis. Results: Of 7.7 million neonatal discharges, 41,814 developed air leak syndrome (5.41/1,000 discharges) in 2016 and 2019, with a mortality rate of 7.2%. Pneumothorax was the most common air leak syndrome (4.3/1,000 discharges). The risk of air leak syndrome increased with decreasing gestational age on univariate analysis. On multivariable analysis, gestational age had a variable effect on developing air leaks depending on the type of air leak syndrome. The presence of meconium aspiration syndrome, congenital diaphragmatic hernia, persistent pulmonary hypertension, and the use of invasive mechanical ventilation were associated with an increased risk of air leak syndrome. There was an increased linear trend in neonatal air leak syndrome prevalence in the United States from 1997 to 2019. Conclusions: Air leak syndrome remains a serious and significant issue among the neonatal population and is associated with high morbidity and mortality. We present a national prevalence and outcomes of various neonatal air leak syndromes in the United States.